|
Mr. Bock has been a director of FEI since December 2004. He has been Executive Chairman of the Board of Directors of Nanosys, Inc., a nanotechnology platform and product development company since October 2003, and was President, CEO and a director of that company from July 2001 to October 2003. Since 1998, he has also been a General Partner at CW Group, a venture capital management firm focused on seed-stage start-ups in the life and physical sciences. From 1988 to 1998, Mr. Bock was general partner of Avalon Ventures, a seed-stage venture capital firm. He was the founder and initial CEO of Metro Biosystems, Inc., Neurocrine Biosciences, Inc., Pharmacopeia, Inc., Argonaut Technologies, Inc., and Caliper Technologies Corp. He was also co-founder of ARIAD Pharmaceuticals, Inc., Athena Neurosciences, Inc., GenPharm International, Vertex Pharmaceuticals, Inc., Onyx Pharmaceuticals, Inc. and Illumina, Inc. He holds a B.A. from Bowdoin College and an M.B.A. from the Anderson School at the University of California, Los Angeles. | 